Some interesting points on Jublia...
Jublia retails at about $1,000 for an 8-milliliter bottle, while a 4-milliliter bottle costs more than $500.
The drug has three different patents, out of which one is set to expire in 2021, and two in 2030.
Valeant quarterly reports show Jublia pulled in $270 million in revenue in the first three quarters of 2015
Valeant was originally guiding for U.S. Jublia sales to peak between $300 and $800
Valeant spent [wasted] $4.5M on a Super Bowl toe-fungus ad
Some interesting points on Jublia... Jublia retails at about...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable